Search Orphan Drug Designations and Approvals
-
Generic Name: | 5,5',5"-[Phosphinothioylidyne-tris(imino-2,1-ethanediyl)]tris[5-methylchelidoninium]trihydroide hexahydrochloride |
---|---|
Date Designated: | 08/20/2003 |
Orphan Designation: | Treatment of pancreatic cancer |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Now Pharm AG 241, route d'Arlon Luxembourg Luxembourg The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-